5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.40▼ | 1.40▼ | 1.40▼ | 1.43▼ | 1.35▲ |
MA10 | 1.47▼ | 1.46▼ | 1.46▼ | 1.46▼ | 1.39▼ |
MA20 | 1.50▼ | 1.50▼ | 1.50▼ | 1.40▼ | 1.55▼ |
MA50 | 1.45▼ | 1.39▼ | 1.38▼ | 1.42▼ | 1.50▼ |
MA100 | 1.41▼ | 1.40▼ | 1.42▼ | 1.56▼ | 1.56▼ |
MA200 | 1.48▼ | 1.53▼ | 1.57▼ | 1.46▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.025▼ | -0.027▼ | -0.026▼ | -0.001▼ | -0.025▼ |
RSI | 35.769▼ | 41.149▼ | 43.231▼ | 45.464▼ | 46.806▼ |
STOCH | 14.672▼ | 14.672▼ | 14.270▼ | 20.825 | 32.045 |
WILL %R | -91.304▼ | -91.304▼ | -91.304▼ | -74.198 | -67.073 |
CCI | -119.048▼ | -114.667▼ | -112.341▼ | -158.941▼ | -36.220 |
Thursday, May 16, 2024 09:30 PM
Velan Inc. (TSX: VLN) (“Velan” or the “Company”), a world-leading manufacturer of industrial valves, announced today its financial results for its fourth quarter and fiscal year ended February 29, 2024.
|
Thursday, May 16, 2024 08:53 AM
Cyclo Therapeutics just reported results for the first quarter of 2024.More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to ...
|
Thursday, May 16, 2024 05:05 AM
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 1.405 | 1.405 | 1.35 | 1.37 | 33,087 |
15/05/24 | 1.47 | 1.47 | 1.40 | 1.43 | 16,466 |
14/05/24 | 1.40 | 1.5372 | 1.40 | 1.41 | 32,350 |
13/05/24 | 1.45 | 1.45 | 1.45 | 1.45 | 0 |
10/05/24 | 1.51 | 1.55 | 1.45 | 1.47 | 34,534 |
09/05/24 | 1.55 | 1.59 | 1.44 | 1.45 | 75,625 |
08/05/24 | 1.53 | 1.5526 | 1.49 | 1.50 | 18,777 |
07/05/24 | 1.51 | 1.58 | 1.501 | 1.51 | 26,280 |
06/05/24 | 1.56 | 1.6199 | 1.50 | 1.53 | 32,031 |
03/05/24 | 1.50 | 1.55 | 1.48 | 1.51 | 26,352 |
|
|
||||
|
|
||||
|
|